MedPath

Evaluation of CT-XPI

Not Applicable
Not yet recruiting
Conditions
CT Scan
Computed Tomography
Registration Number
NCT07192133
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imaging. The main question it aims to answer is:

* Does the new contrast-free method provide more information about lung perfusion than SOC?

Participants will undergo a 30 minute chest CT.

Detailed Description

The purpose of the study is to evaluate X-ray Pulsatility Index using prospectively acquired dynamic CT, which is different from conventional static CT scans.

The primary objective of this study is to collect dynamic CT scan data with human participants using high frame rate imaging methods to produce a map of lung perfusion.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age 18 years or older
  • Able to sign and date the informed consent form
  • Will undergo a clinically-indicated CT exam of the head, neck, chest, abdomen, pelvis, or extremities
Exclusion Criteria
  • Pregnant or lactating
  • In need of urgent or emergent care
  • Have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the participant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Lung x-ray pulsatility index (XPI)30 minutes

XPI, a representative of lung perfusion, will be measured using CT images. The dynamic x-ray attenuation from each pixel is analyzed using spectral analysis.

Magnitude of XPI30 minutes

Measured as a number, this corresponds to the magnitude of the relative change of signal.

Presence of XPI30 minutes

This will be evaluated quantitatively using CNR (contrast to noise) measurements which uses a region of interest in the lungs and a region of interest outside of the lungs.

Spatial distribution of XPI signal30 minutes

This is a subjective evaluation, routinely done clinically with other modalities that measure lung perfusion. Researchers evaluate how homogenous (smooth) the signal is over the lungs and look for perfusion defects (areas with little or no XPI) which would indicate pathology.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin - Madison

🇺🇸

Madison, Wisconsin, United States

University of Wisconsin - Madison
🇺🇸Madison, Wisconsin, United States
Stephanie Wilson
Contact
SWilson8@uwhealth.org
Matthew Smith, MD, PhD
Principal Investigator
Timothy Szczykutowicz, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.